Summary
Johnson & Johnson announced a key leadership change in its financial reporting function. Ronald A. Kapusta, the current Controller and Chief Accounting Officer, has elected to retire effective December 27, 2019. This transition marks the end of Mr. Kapusta's tenure, and the company has appointed Robert J. Decker, Jr. to succeed him in this critical role, also effective December 27, 2019. Mr. Decker's appointment is significant given his extensive experience within Johnson & Johnson, having held various finance roles across the company's diverse segments since 1993. His most recent position as Assistant Corporate Controller, preceded by leadership roles such as CFO of North America Medical Devices, demonstrates a deep understanding of the company's financial operations. Investors can view this as a move towards internal continuity within the financial leadership team, leveraging established talent.
Key Highlights
- 1Ronald A. Kapusta, Controller and Chief Accounting Officer, will retire effective December 27, 2019.
- 2Robert J. Decker, Jr. has been appointed as the new Controller and Chief Accounting Officer, effective December 27, 2019.
- 3Mr. Decker has a long tenure with Johnson & Johnson, starting in June 1993.
- 4Mr. Decker has held increasing responsibilities across Consumer, Pharmaceutical, Medical Devices, and Corporate divisions.
- 5Prior to this appointment, Mr. Decker served as Assistant Corporate Controller since August 2017.
- 6Mr. Decker previously held CFO roles within the North America Medical Devices and DePuy Synthes divisions.
- 7Mr. Decker is a CPA and CMA with a Bachelor of Science in Accounting from Rider University.